Pyxis Oncology Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Pyxis Oncology stock has a consensus rating of "Strong Buy" and an average price target of $6.89. The average 1-year stock price forecast is 241.09% higher than the current stock price, while the lowest is $5.00 (+147.52%) and the highest is $9.00 (+345.54%).

Price Target: $6.89 (+241.09%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$6.89	$7.00	$9.00
Change	+147.52%	+241.09%	+246.53%	+345.54%

Analyst Ratings

The average analyst rating for Pyxis Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	3	3	3
Buy	2	2	2	2	2	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	5	5	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Driscoll Wedbush	Wedbush	Buy Initiates $6	Buy	Initiates	$6	+197.03%	May 5, 2026
Bradley Canino Stifel	Stifel	Strong Buy Maintains $9 → $8	Strong Buy	Maintains	$9 → $8	+296.04%	Mar 24, 2026
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+246.53%	Mar 24, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $8 → $5	Buy	Maintains	$8 → $5	+147.52%	Dec 19, 2025
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $5 → $7	Strong Buy	Maintains	$5 → $7	+246.53%	Dec 19, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

39.67K

from 13.86M

-99.71%

from 13.86M

Revenue Next Year

2.83M

from 39.67K

7,041.81%

from 39.67K

EPS This Year

-1.27

from -1.28

EPS Next Year

-1.30

from -1.27

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	16.15M	13.86M	39.67K	2.83M
Revenue Growth	-	-	-	-	-14.17%	-99.71%	7,041.81%
EPS	-8.95	-3.65	-1.85	-1.32	-1.28	-1.27	-1.30
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	367,500	26.3M
Avg	39,668	2.8M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-97.3%	66,074.6%
Avg	-99.7%	7,041.8%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.00	-0.89
Avg	-1.27	-1.30
Low	-1.53	-1.66

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.